-
ʻO Sacubitril Hemicalcium
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP ʻO Sacubitril Hemicalcium I-Hale -
Sofosbuvir
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Sofosbuvir HCV I-Hale 32048 √ -
Ribociclib 1374639-75-4
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Ribociclib 1374639-75-4 HR-maikaʻi, HER2-negative Andvance ormetastatic breast Cancers Novartis
Nā lāʻau lapaʻauIun.27, 2028 -
Rivaroxaban
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Rivaroxaban ʻO ka lāʻau anticoagulant I-Hale TDP -
ʻO Rosuvastatin Calcium
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP ʻO Rosuvastatin Calcium Hypercholesterolemia I loko o ka Hale/CEP 20705 √ CEP2015-240 -
ʻO Pitavastatin Calcium
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP ʻO Pitavastatin Calcium Hypercholesterolemia I-Hale -
Pregabalin
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Pregabalin Epilepsy/Neuralgia I-Hale/EP 22223 √ CEP2016-141 -
Obeticholic Acid
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Obeticholic Acid ʻO ka cholangitis biliary I-Hale -
Niraparib 1038915-60-4
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Niraparib 1038915-60-4 ʻOvarian/Fallopian, tube/primary peritoneal cancer Tesaro Ian.8, 2028 -
Ledipasvir Actone /PVP
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Ledipasvir Actone /PVP HCV I-Hale √ -
LCZ696(Sacubitril + Valsartan)
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP LCZ696(Sacubitril + Valsartan) ʻAʻohe puʻuwai I-Hale √ -
Lenalidomide
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Lenalidomide Laau oncology I-Hale 31804 √